Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction

Authors Information
Article Notes and Dates
To Cite : Caviglia G P, Pellicano R. Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction, Hepat Mon. 2015 ;15(8):e30853. doi: 10.5812/hepatmon.30853.
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
  • 1. Yang ZH, Yang SX, Qin CZ, Chen YX. Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis. Hepat Mon. 2015; 15(5)[DOI][PubMed]
  • 2. Caviglia GP, Ciancio A, Rosso C, Abate ML, Olivero A, Pellicano R, et al. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Ann Hepatol. 2013; 13(1): 91-7[PubMed]
  • 3. Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut. 2008; 57(4): 500-6[DOI][PubMed]
  • 4. Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014; 60(5): 1063-74[DOI][PubMed]
  • 5. Cusi K, Chang Z, Harrison S, Lomonaco R, Bril F, Orsak B, et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol. 2014; 60(1): 167-74[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check